• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Laboratory Corp American Holdings (NY: LH )

    227.17 +0.07 (+0.03%)
    Official Closing Price Updated: 7:00 PM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 401,255
    Open 227.42
    Bid (Size) 224.11 (1)
    Ask (Size) 232.09 (1)
    Prev. Close 227.10
    Today's Range 225.62 - 229.62
    52wk Range 191.97 - 239.50
    Shares Outstanding 83,700,000
    Dividend Yield 1.27%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience
    From Praia Health
    Via Business Wire
    Expert Outlook: Labcorp Holdings Through The Eyes Of 12 Analysts
    Via Benzinga

    Performance

    YTD
    -2.32%
    -2.32%
    1 Month
    +7.14%
    +7.14%
    3 Month
    -0.61%
    -0.61%
    6 Month
    +13.00%
    +13.00%
    1 Year
    +8.41%
    +8.41%

    More News

    Read More
    Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact
    Via Benzinga
    Topics Earnings
    Exposures Financial
    UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Analyst Ratings For Labcorp Holdings
    Via Benzinga
    Analyst Expectations For Labcorp Holdings's Future
    Via Benzinga
    LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings
    Via Benzinga
    NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
    From NOWDiagnostics, Inc.
    Via Business Wire
    Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
    Via Benzinga
    DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
    Via Benzinga
    Labcorp Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
    Via Benzinga
    Forecasting The Future: 4 Analyst Projections For Labcorp Holdings
    Via Benzinga
    LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
    Via Benzinga
    Is This Telehealth Stock a Buy After the Recent Pullback?
    Via MarketBeat
    Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
    Via AB Newswire
    Analyst Ratings For Laboratory Corp
    Via Benzinga
    Laboratory Corp's Ex-Dividend Date Is Monday, Here's What You Need To Know
    Via Benzinga
    Earnings Scheduled For February 15, 2024
    Via Benzinga
    Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
    Via Talk Markets
    Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal
    Via Benzinga
    LH Stock Earnings: Laboratory Corp Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
    From Xcell Biosciences Inc.
    Via Business Wire
    Labcorp Expands Diagnostic Reach With Strategic Deal For Select Assets Of BioReference Health
    Via Benzinga
    LifeMD Shares Come Back to Life on GLP-1 Business Growth
    Via MarketBeat
    Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.